Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital(TM) PCR High Complexity Assays

(NasdaqGM:BDSX), LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) — Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which Biodesix will conduct the development, clinical validation, and regulatory submissions of in vitro diagnostic (IVD) assays to enable highly sensitive detection of multiple genomic markers focused […]

Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital(TM) PCR High Complexity Assays

Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital(TM) PCR High Complexity Assays Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing GlobeNewswire October 22, 2025 LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) — Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced

Energy Fuels Announces Call Details for Q3-2025 Earnings

Conference Call and Webcast at9:00 AM MTonTuesday, November 4, 2025 Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR),a leading U.S. producer of uranium, rare earth elements, and critical minerals, will hold a conference call onTuesday, November 4, 2025,at9:00 AM Mountain Timeto discuss its financial results for Q3-2025. https://mma.prnewswire.com/media/2801944/Energy_Fuels_Inc__Energy_Fuels_Announces_Call_Details_for_Q3_202.jpg Financial results and other highlights will be

Taylor Morrison Reports Third Quarter 2025 Results

Taylor Morrison Home Corporation (NYSE: TMHC), a leading national land developer and homebuilder, announced results for the third quarter ended Sept. 30, 2025. Reported net income was $201 million, or $2.01 per diluted share, while adjusted net income was $211 million, or $2.11 per diluted share. https://mma.prnewswire.com/media/2670373/TM_Corp_Logo.jpg Third quarter 2025 highlights: — Home closings revenue

JASCAYD(R) (nerandomilast) approved in China for the treatment of idiopathic pulmonary fibrosis (IPF)

Ingelheim, Germany Approval is based on results from Phase III FIBRONEER(TM)-IPF trial, which showed statistically significant improvements in the absolute change from baseline in Forced Vital Capacity at 52 weeks with nerandomilast 18 mg and 9 mg versus placebo in adults with idiopathic pulmonary fibrosis (IPF)1,2 Nerandomilast was included in the priority review by the

JASCAYD(R) (nerandomilast) approved in China for the treatment of idiopathic pulmonary fibrosis (IPF)

JASCAYD(R) (nerandomilast) approved in China for the treatment of idiopathic pulmonary fibrosis (IPF) GlobeNewswire October 22, 2025 Ingelheim, Germany Approval is based on results from Phase III FIBRONEER(TM)-IPF trial, which showed statistically significant improvements in the absolute change from baseline in Forced Vital Capacity at 52 weeks with nerandomilast 18 mg and 9 mg versus

Unlimited Japan eSIM with No Fair Use Limits – Powered by KDDI, from TravelKon

Experience Japan with peace of mind. TravelKon’s eSIM offers truly unlimited high-speed data on the premium KDDI network, with straightforward plans starting from A$22 for 4 to 31 days. SYDNEY, AU / ACCESS Newswire / October 22, 2025 / The allure of Japan is undeniable, from Tokyo’s dynamic cityscapes to Kyoto’s serene temples and Hokkaido’s

Shield AI Unveils X-BAT, an AI-Piloted VTOL Fighter Jet for Contested Environments

Shield AI today announced the unveiling ofX-BAT, an AI-piloted, vertical takeoff and landing (VTOL) fighter jet designed for expeditionary and maritime operations in contested environments. https://mma.prnewswire.com/media/2802416/Shield_AI_announced_the_unveiling_of_X_BAT.jpg “At Shield AI, we believe the greatest victory requires no war. To make that belief real, we're executing a simple but ambitious master plan: prove the value of autonomy,

Doing the Good Work: SM underscores practical sustainability at industry forum

SM Investments Corporation (SM Investments), the parent company of the SM group, emphasized its practical approach to sustainability atThe Dirty Work of Doing Good, a sustainability conference organized by the French Chamber of Commerce and Industry in the Philippines. https://mma.prnewswire.com/media/1880730/Logo.jpg Addressing industry leaders, sustainability advocates, and changemakers, SM Investments Head of Investor Relations and Sustainability

DataVault AI and Wellgistics Health Announce Plans for PharmacyChain(TM) to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency and Patient Outcomes

(NASDAQ:DVLT),(NASDAQ:WGRX), BEAVERTON, Ore., Oct. 22, 2025 (GLOBE NEWSWIRE) — via IBN — DataVault AI, Inc. (“DataVault”) (NASDAQ: DVLT), leading the way in AI data experience, valuation, and monetization, and Wellgistics Health, Inc. (“Wellgistics”) (NASDAQ: WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the two companies have entered

Scroll to Top